| 01/12/22 | Eli Lilly : a finalisé l'acquisition d'Akouos | |
| 30/11/22 | Eli Lilly : vers l'acquisition de 81.1% des actions d'Akouos | |
| 19/10/22 | Wall Street sluit hoger | |
| 19/10/22 | Wall Street houdt winst vast | |
| 19/10/22 | MÄRKTE USA/Börsen setzen Erholung fort |
| 1 day | +1.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 43 | 01/01/2016 | |
Jean Phillips
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aaron Tward
CTO | Chief Tech/Sci/R&D Officer | - | 10/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jean Bennett
BRD | Director/Board Member | 71 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/12/22 | Issuer sale | Chief Financial Officer | 150,000 | 0.4060% | ||
| 01/12/22 | Issuer sale | Director | 16,000 | 0.0433% | ||
| 01/12/22 | Issuer sale | Director | 16,000 | 0.0433% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.06% | +0.91% | - | - | 491M | ||
| 0.00% | -1.53% | +66.84% | +121.47% | 55.63B | ||
| +0.82% | +15.05% | +79.52% | +88.67% | 52.25B | ||
| +0.98% | +2.42% | -13.24% | -13.67% | 23.07B | ||
| +1.47% | +7.60% | +5.43% | +422.15% | 22.41B | ||
| +6.78% | +14.77% | +37.54% | -1.86% | 17.32B | ||
| +1.12% | +4.14% | +31.10% | -31.99% | 15.94B | ||
| +1.61% | +8.20% | +26.06% | +193.04% | 13.77B | ||
| -3.35% | +8.96% | +134.32% | +282.61% | 13.47B | ||
| +4.21% | +11.01% | +33.13% | - | 12.43B | ||
| Average | +1.44% | +4.78% | +44.52% | +132.55% | 25.14B | |
| Weighted average by Cap. | +1.13% | +5.13% | +50.44% | +123.71% |
Employees
103
















